SEATTLE, December 11, 2019-- AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals, is significantly expanding its CDMO services with plasmid DNA (pDNA) offerings from its Heidelberg site in Germany. With the demand for pDNA growing rapidly, AGC Biologics is leveraging 25 years of experience and comprehensive in-house analytics development to ensure customers short and dependable timelines.
AGC Biologics Expands Plasmid DNA Offering
by Diane Hunt Published on 12/11/19 1:42 PM News
Learn More
Follow Us
Content not found